复星医药、中汇人寿等成立股权投资基金

Group 1 - The core point of the article is the establishment of Zhonghui Fuhong (Tianjin) Equity Investment Fund Partnership (Limited Partnership) with a capital contribution of 547 million yuan, focusing on private equity investment, investment management, and asset management activities [1] - The partnership is jointly funded by Zhonghui Life Insurance Co., Ltd., a wholly-owned subsidiary of Fosun Pharma (600196) Shanghai Fosun Pharma Industry Development Co., Ltd., and Hongyi Private Equity Fund Management (Tianjin) Partnership (Limited Partnership) [1] - The establishment of this fund indicates a strategic move in the private equity investment sector, highlighting the collaboration between insurance and pharmaceutical companies [1]